| J01DD04 |
G |
Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) - |
6786 |
97386/12 |
LEBACEF |
0.5g |
1 |
Injectable powder for solution+diluent |
IM |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
511,940 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (sodium) - 0.5g |
6787 |
97389/12 |
LEBACEF |
0.5g |
1 |
Injectable powder for solution+diluent |
IV |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
511,940 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (sodium) - 0.5g |
6891 |
97494/12 |
LEBACEF |
0.5g |
10 |
Injectable powder for solution |
IV/IM |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
3,455,595 L.L |
23.08 |
B |
|
|
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (sodium) - 0.5g |
7618 |
45714/1 |
LEBACEF |
0.5g |
1 |
Injectable powder for solution+diluent |
IV |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
433,869 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) - |
11034 |
104022/1 |
LEBACEF |
0.5g |
1 |
Injectable powder for solution+diluent |
IM |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
403,153 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) - |
11721 |
142023/1 |
LEBACEF |
0.5g |
1 |
Injectable powder for solution+diluent |
IM |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
403,153 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (sodium) - 0.5g |
11722 |
100323/1 |
LEBACEF |
0.5g |
10 |
Injectable powder for solution |
IV/IM |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
3,455,595 L.L |
23.08 |
B |
|
|
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (sodium) - 0.5g |
11723 |
81923/1 |
LEBACEF |
0.5g |
1 |
Injectable powder for solution+diluent |
IM |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
511,940 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (sodium) - 0.5g |
11724 |
81823/1 |
LEBACEF |
0.5g |
1 |
Injectable powder for solution+diluent |
IV |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
511,940 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (disodium) (Vial) - 500mg, Lidocaine (ampoule) - |
5202 |
194125/05 |
MEDAXONUM |
500mg |
1 |
Injectable powder for solution+diluent |
IM |
New Allpharma |
Medochemie Ltd |
Cyprus |
307,740 L.L |
23.08 |
A1 |
Medochemie Ltd |
Cyprus |
2/4/2025 |
|
| J01DD04 |
G |
Ceftriaxone (sodium) - 500mg |
1618 |
405685/00 |
TRIAXONE |
500mg |
1 x 2ml |
Injectable powder for solution+diluent |
IM |
Pharmanet Drugstore S.A.R.L. |
Julphar |
United Arab Emirates |
356,118 L.L |
23.08 |
A1 |
|
|
2/4/2025 |
|
